An experiment was conducted to estimate relative bioavailability (RBV) of Zn in Zinc proteinate and Zinc methionine compared to Zinc acetate as the standard. A total of 432, 1-day-old male broiler chicks was assigned randomly to dietary treatments which included the basal maize–soyabean meal diet (24 mg Zn kg −1 DM) supplemented with 0, 30, 60, or 90 mg kg −1 added Zn as reagent grade Zinc acetate or 30 or 60 mg kg −1 added Zn from Zinc methionine or Zinc proteinate fed for 3, 6, or 9 days. Accumulation of Zn in bone increased ( P<0.001) with supplemental Zn and age. Bone Zn concentration was greater ( P<0.001) in chicks given Zinc proteinate. Hepatic and mucosal metallothionein (MT) increased ( P<0.001) with supplemented Zn and age. Using Zinc acetate as a standard (1.00) in multiple linear regressions gave estimated RBV values of 1.10, 1.24, and 1.16 for Zinc proteinate and 0.88, 0.91 and 0.78 for Zinc methionine at 3, 6, and 9 days, respectively, based on bone Zn concentrations. Similar estimates were calculated using mucosal MT. The coefficient of determination was greater for the mucosal MT regression at 3 days compared to that for bone Zn. Mucosal MT appears to be a suitable criterion to estimate bioavailability of Zn sources during short term trials.